Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Liquidity: $8,975M in Q3 2026, down 8.0% from a year earlier.
Latest, Q3 2026
8,975
Period ended Sep 30, 2026
Change on a year earlier
-8.0%
9,753 in Q3 2025
History
31 quarters
Since Q4 2018
Sources
31
Documents cited below
Where the Q3 2026 figure comes from
“|| Total liquidity | 8 975 | 11 590 | 9 753”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Total Liquidity ($M), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/nd-total-liquidity
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.